
-
2009 September 01
Company Description
Perseid Therapeutics LLC was founded in September 2009 as a joint venture between Maxygen, Inc.
Perseid Therapeutics LLC was founded in September 2009 as a joint venture between Maxygen, Inc. and Astellas Pharma Inc. to co-develop Maxygen's technology assets in protein pharmaceuticals, including MAXY-4, a next-generation CTLA4-Ig. Under the terms of the agreement, Astellas received worldwide rights to commercialize MAXY-4 for autoimmune disease and transplantation.
-
Manufacturer:
Science and Engineering -
Formed:
September 1, 2009 -
Company Website:
-
Company E-mail:
-
Company Address:
515 Galveston DriveRedwood City, CAUnited States -
CEO:
- Grant Yonehiro
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits